Forum Financial Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Forum Financial Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,187	Closed	-$308K	–	419
2025 Q4	$308K	Buy	5,187 +100	+2%	+$5.44K	﹤0.01%	734
2025 Q3	$276K	Buy	+5,087	New	+$291K	﹤0.01%	792
2025 Q2	–	Sell	-3,207	Closed	-$227K	–	957
2025 Q1	$227K	Sell	3,207 -1,324	-29%	-$89.1K	﹤0.01%	750
2024 Q4	$298K	Buy	+4,531	New	+$303K	﹤0.01%	621

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Forum Financial Management's BMRN Position: Q1 2026 in Review

Forum Financial Management sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2026, closing a stake of 5,187 shares — an estimated $308K sold.

Forum Financial Management first reported a position in BMRN in Q4 2024 and held it in 4 quarters. The position peaked at $308K in Q4 2025. 557 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

Forum Financial Management reported no remaining BioMarin Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Forum Financial Management sold 5,187 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $308K.
Forum Financial Management first reported a position in BioMarin Pharmaceuticals in Q4 2024 and held it in 4 quarters.
Forum Financial Management's BioMarin Pharmaceuticals position peaked at $308K in Q4 2025.
557 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Forum Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.